02/01/2012 - 2:44pm

Impax Pharmaceuticals said Wednesday that it obtained exclusive U.S. commercial rights to a drug for migraine headaches made by AstraZeneca.

02/01/2012 - 12:16pm

A possible pill mix-up has prompted Pfizer to recall more than two dozen lots of a prescription contraceptive drug, the drug maker said.

02/01/2012 - 11:26am

The Food and Drug Administration has approved a drug made by Novartis that is designed to prevent tumors in the gastrointestinal tract from recurring after surgical removal, the agency said.

02/01/2012 - 10:23am

A former Johnson & Johnson executive has been appointed to serve as interim CEO for Savient Pharmaceuticals.

01/31/2012 - 2:10pm

A goal to standardize risk evaluation and mitigation strategies and modernize the U.S. drug safety system in a proposed reauthorization of the Prescription Drug User Fee Act has drawn support from the country's main chain retail pharmacy lobby.

01/31/2012 - 10:50am

The Food and Drug Administration has approved a new treatment for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim, the drug makers said.

01/30/2012 - 3:45pm

Watson Pharmaceuticals is planning to open a global research and development technology center.

01/30/2012 - 12:47pm

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

01/30/2012 - 10:58am

Iceland-based drug maker Actavis and Poland-based Bioton have formed a partnership that they said would "shake up" the diabetes market.